Lysa
2021_LYSA_The landscape of copy number variations in classical Hodgkin lymphoma: a joint KU Leuven and LYSA study on cell-free DNA
Blood Advances 2021
En savoir plus
Lysa
2021_LYSA_Oxaliplatin before autologous transplantation in combination with high-dose cytarabine and rituximab provides linger disease control than cisplatin or carboplatin in patients with mantle-cell lymphoma: results from LyMA prospective trial
Bone Marrow Transplant . 2021 Jul;56(7):1700-1709.
En savoir plus
Lysa
2021_LYSA_Adverse outcome in follicular lymphoma is associated with MYC rearrangements but not MYC extra copies
Br J Haematol . 2021 Jul;194(2):382-392.
En savoir plus
Lysa
2021_LYSA_Extracellular vesicles shed by follicular lymphoma B cells promote polarization of the bone marrow stromal cell niche
Blood . 2021 Jul 8;138(1):57-70.
En savoir plus
Lysa
2021_LYSA_Incidence of central nervous system relapses in patients with DLBCL treated with lenalidomide as maintenance after R-CHOP
Blood Adv . 2021 Aug 10;5(15):2965-2968.
En savoir plus
Lysa
2021_LYSA_High-grade Follicular Lymphomas Exhibit Clinicopathologic, Cytogenetic, and Molecular Diversity Extending Beyond Grades 3A and 3B
Am J Surg Pathol . 2021 Oct 1;45(10):1324-1336.
En savoir plus
Lysa
2021_LYSA_Outcomes after first-line immunochemotherapy for primary mediastinal B cell lymphoma patients: a LYSA study
Blood Adv . 2021 Oct 12;5(19):3862-3872.
En savoir plus
Lysa
2021_LYSA_Gonadal Function Recovery in Patients With Advanced Hodgkin Lymphoma Treated With a PET-Adapted Regimen: Prospective Analysis of a Randomized Phase III Trial (AHL2011)
J Clin Oncol . 2021 Oct 10;39(29):3251-3260.
En savoir plus
Lysa
2021_LYSA_Fully automatic segmentation of diffuse large B cell lymphoma lesions on 3D FDG-PET/CT for total metabolic tumor volume prediction using a convolutional neural network
Eur J Nucl Med Mol Imaging . 2021 May;48(5):1362-1370. doi: 10.1007/s00259-020-05080-7.
En savoir plus
Lysa
2021_LYSA_Obinutuzumab vs rituximab for advanced DLBCL: a PET-guided and randomized phase 3 study by LYSA
Blood . 2021 Apr 29;137(17):2307-2320. doi: 10.1182/blood.2020008750.
En savoir plus
Lysa
2021_LYSA_Lenalidomide tiggers T-cell effector functions in vivo in patients with follicular lymphoma
Blood Adv . 2021 Apr 27;5(8):2063-2074.
En savoir plus
Lysa
2021_LYSA_Sub-Cutaneous Rituximab-MiniCHOP compared to Sub-Cutaneous Rituximab-MiniCHOP plus Lenalidomide in Diffuse Large B Cell Lymphoma for Patients of 80 Years or older.
J Clin Oncol . 2021 Apr 10;39(11):1203-1213. doi: 10.1200/JCO.20.02666.
En savoir plus
Lysa
2021_LYSA_A French multicentric prospective prognostic cohort with epidemiological, clinical, biological and treatment information to improve knowledge on lymphoma patients: study protocol of the « REal world dAta in LYmphoma and survival in adults » (REALYSA) cohort
BMC Public Health . 2021 Mar 2;21(1):432. doi: 10.1186/s12889-021-10433-4.
En savoir plus
Lysa
2021_LYSA_Ibrutinib, obinutuzumab, and venetoclax in relapsed and untreated patients with mantle cell lyphoma: a phase 1/2 trial
Blood . 2021 Feb 18;137(7):877-887. doi: 10.1182/blood.2020008727.
En savoir plus
Lysa
2021_LYSA_BeEAM (bendamustine, etoposide, cytarabine, melphalan) prior to autologous stem cell transplant for chemosensitive relapses in patients with follicular lymphoma: a prospective multicentre phase II study in Lymphoma Study Association centres
Br J Haematol . 2021 Feb;192(3):e94-e98. doi: 10.1111/bjh.17279.
En savoir plus
Lysa
2021_LYSA_Integrative analysis of a phase 2 trial combining lenalidomide with CHOP in angioimmunoblastic T-cell lymphoma
Blood Adv . 2021 Jan 26;5(2):539-548. doi: 10.1182/bloodadvances.2020003081.
En savoir plus
Lysa
2021_LYSA_Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial
Leukemia . 2021 Jan;35(1):143-155. doi: 10.1038/s41375-020-0838-5
En savoir plus
Lysa
2021_LYSA_Combining Brentuximab Vedotin With Dexamethasone, High-Dose Cytarabine and Cisplatin as Salvage Treatment in Relapsed or Refractory Hodgkin Lymphoma: The Phase II HOVON/LLPC Transplant BRaVE Study
Haematologica . 2021 Apr 1;106(4):1129-1137.
En savoir plus
Lysa
2021_LYSA_A standardized medical report template for CAR T-Cell therapy patients: Guidelines of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)
Bull Cancer . 2021 Dec;108(12S):S82-S86.
En savoir plus
Lysa
2021_LYSA_Nonclassical Monocytes Are Prone to Migrate Into Tumor in Diffuse Large B-Cell Lymphoma
Front Immunol . 2021 Dec 16;12:755623.
En savoir plus
Lysa
2021_LYSA_Current Role of Functional Imaging in the Management of Lymphoma
Curr Oncol Rep . 2021 Nov 4;23(12):144.
En savoir plus
Lysa
2021_LYSA_Primary refractory follicular lymphoma: a poor outcome entity with high risk of transformation to aggressive B cell lymphoma
Eur J Cancer . 2021 Nov;157:132-139.
En savoir plus
Lysa
2021_LYSA_FDG-PET/CT in Lymphoma: Where Do We Go Now?
Cancers (Basel) . 2021 Oct 18;13(20):5222.
En savoir plus
Lysa
2021_LYSA_DESCAR-T, le registre national des patients traités par CAR-T Cells
Bull Cancer . 2021 Oct;108(10S):S143-S154.
En savoir plus
Lysa
2021_LYSA_Pembrolizumab in the treatment of refractory primary mediastinal large B-cell lymphoma: safety and efficacy
Expert Rev Anticancer Ther . 2021 Sep;21(9):941-956.
En savoir plus
Lysa
2021_LYSA_Long-term survival of patients with mantle cell lymphoma after autologous haematopoietic stem-cell transplantation in first remission: a post-hoc analysis of an open-label, multicentre, randomised, phase 3 trial
Lancet Haematol . 2021 Sep;8(9):e648-e657.
En savoir plus
Lysa
2021_LYSA_Super-enhancer-based identification of a BATF3/IL-2R-module reveals vulnerabilities in anaplastic large cell lymphoma
Nat Commun . 2021 Sep 22;12(1):5577.
En savoir plus
Lysa
2021_LYSA_Deep-Learning Assessed Muscular Hypodensity Independently Predicts Mortality in DLBCL Patients Younger Than 60 Years
Cancers (Basel) . 2021 Sep 7;13(18):4503.
En savoir plus
Lysa
2021_LYSA_Prolonged in-hospital stay and higher mortality after Covid-19 among patients with non-Hodgkin lymphoma treated with B-cell depleting immunotherapy
Am J Hematol . 2021 Aug 1;96(8):934-944. doi: 10.1002/ajh.26209.
En savoir plus
Lysa
2021_LYSA_Total tumor burden in lymphoma – an evolving strong prognostic parameter
Br J Radiol . 2021 Nov 1;94(1127):20210448.
En savoir plus
Lysa
2021_LYSA_Detection of Gene Fusion Transcripts in Peripheral T-Cell Lymphoma Using a Multiplexed Targeted Sequencing Assay
J Mol Diagn . 2021 Aug;23(8):929-940.
En savoir plus
Lysa
2021_LYSA_Follicular lymphoma triggers phenotypic and functional remodeling of the human lymphoid stromal cell landscape
Immunity . 2021 Aug 10;54(8):1901.
En savoir plus
Lysa
2021_LYSA_New Approaches in Characterization of Lesions Dissemination in DLBCL Patients on Baseline PET/CT
Cancers (Basel) . 2021 Aug 8;13(16):3998.
En savoir plus
Lysa
2021_LYSA_Chronic T cell receptor stimulation unmasks NK receptor signaling in peripheral T cell lymphomas via epigenetic reprogramming
J Clin Invest . 2021 Jul 1;131(13):e139675.
En savoir plus
Lysa
2021_LYSA_Lack of intrafollicular memory CD4 + T cells is predictive of early clinical failure in newly diagnosed follicular lymphoma
Blood Cancer J . 2021 Jul 15;11(7):130.
En savoir plus
Lysa
2021_LYSA_LRPAP1 autoantibodies in mantle cell lymphoma are associated with superior outcome
Blood . 2021 Jun 10;137(23):3251-3258.
En savoir plus
Lysa
2021_LYSA_Fusion transcripts FYN-TRAF3IP2 and KHDRBS1-LCK hijack T cell receptor signaling in peripheral T-cell lymphoma, not otherwise specified
Nat Commun . 2021 Jun 17;12(1):3705.
En savoir plus
Lysa
2021_LYSA_A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL
Blood . 2021 May 13;137(19):2646-2656.
En savoir plus
Lysa
2021_LYSA_Risk of relapse after anti-PD1 discontinuation in patients with Hodgkin lymphoma
Eur J Nucl Med Mol Imaging . 2021 May;48(5):1699-1700.
En savoir plus
Lysa
2021_LYSA_Mutational landscape of gray zone lymphoma.
Blood . 2021 Apr 1;137(13):1765-1776.
En savoir plus
Lysa
2021_LYSA_c-Rel Is the Pivotal NF-κB Subunit in Germinal Center Diffuse Large B-Cell Lymphoma: A LYSA Study
Front Oncol . 2021 Apr 20;11:638897.
En savoir plus
Lysa
2021_LYSA_Outcomes of older patients with follicular lymphoma using individual data from 5922 patients in 18 randomized controlled trials
Blood Adv . 2021 Mar 23;5(6):1737-1745.
En savoir plus
Lysa
2021_LYSA_Early progression of disease in follicular lymphoma is a robust correlate but not a surrogate for overall survival
Blood Adv . 2021 Mar 23;5(6):1729-1732.
En savoir plus
Lysa
2021_LYSA_Improving high-resolution copy number variation analysis from next generation sequencing using unique molecular identifiers
BMC Bioinformatics . 2021 Mar 12;22(1):120. doi: 10.1186/s12859-021-04060-4.
En savoir plus
Lysa
2021_LYSA_Upfront eBEACOPP chemotherapy without consolidation radiotherapy in early-stage unfavourable Hodgkin lymphoma
Lancet Oncol . 2021 Feb;22(2):161-162. doi: 10.1016/S1470-2045(20)30640-9.
En savoir plus
Lysa
2021_LYSA_EHA/ESMO Clinical Practice Guidelines for the Management of Malignant Lymphoma: Recommendations for the Second Phase of the COVID-19 Pandemic
Hemasphere . 2021 Jan 27;5(2):e529. doi: 10.1097/HS9.0000000000000529.
En savoir plus
Lysa
2021_LYSA_The impact of SAMHD1 expression and mutation status in mantle cell lymphoma: An analysis of the MCL Younger and Elderly trial
Int J Cancer . 2021 Jan 1;148(1):150-160. doi: 10.1002/ijc.33202
En savoir plus
Lysa
2021_LYSA_Classical Hodgkin lymphoma
Lancet . 2021 Oct 23;398(10310):1518-1527. doi: 10.1016/S0140-6736(20)32207-8.
En savoir plus
Lysa
2021_LYSA_Deep-Learning 18F-FDG Uptake Classification Enables Total Metabolic Tumor Volume Estimation in Diffuse Large B-Cell Lymphoma
J Nucl Med . 2021 Jan;62(1):30-36. doi: 10.2967/jnumed.120.242412
En savoir plus